✦ LIBER ✦

Therapeutic Hotline: Cysteinyl leukotriene receptor antagonist montelukast in the treatment of atopic dermatitis

✍ Scribed by Valentina Broshtilova; Mary Gantcheva

Book ID: 109116051
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 57 KB
Volume: 23
Category: Article
ISSN: 1396-0296
DOI: 10.1111/j.1529-8019.2009.01295.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind trial of the H2 receptor

A double-blind trial of the H2 receptor antagonist cimetidine, and the H1 receptor antagonist promethazine hydrochloride in the treatment of atopic dermatitis

✍ I. S. FOULDS; R. M. MacKIE 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

Comparison of glucocorticoid and cystein

Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigs

✍ E. A. Leick-maldonado; F. U. Kay; M. C. Leonhardt; D. I. Kasahara; C. M. Prado; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 993 KB

A double blind trial of H1and H2receptor

A double blind trial of H1and H2receptor antagonists in the treatment of atopic dermatitis

✍ P. J. Frosch; H. J. Schwanitz; E. Macher 📂 Article 📅 1984 🏛 Springer-Verlag 🌐 English ⚖ 426 KB

Eighteen patients with atopic dermatitis were randomly chosen for a clinical trial to compare the action of the H2 receptor antagonist cimetidine in combination with the H1 receptor antagonist chorpheniramine against the chlorpheniramine alone and against placebo. Each treatment period lasted for 4

Quantification of montelukast, a selecti

Quantification of montelukast, a selective cysteinyl leukotriene receptor (CysLT1) antagonist in human plasma by liquid chromatography–mass spectrometry: validation and its application to a human pharmacokinetic study

✍ D. Vijaya Bharathi; Kishore Kumar Hotha; B. Jagadeesh; Ramesh Mullangi; A. Naidu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 2 views

Investigation on a novel and specific le

Investigation on a novel and specific leukotriene B4 receptor antagonist in the treatment of stable plaque psoriasis

✍ Van Pelt; DE Jong; Seijger; Van Hooijdonk; DE Bakker; Van Vlijmen; Parker; Van E 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB

The aim of the present study was to investigate the efficacy and clinical tolerability of the specific leukotriene B4 receptor antagonist VML295 in the treatment of stable plaque psoriasis. Immunohistochemical and flow cytometrical methods were used to assess the effects on inflammation and epiderma

Addition of topical pimecrolimus to once

Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial

✍ J.M. Spergel; M. Boguniewicz; A.S. Paller; A.A. Hebert; P.R. Gallagher; C. McCor 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB